,,iii  #aag? ,,congress  #b;d ,session  
,s4 ,,res4 #fjb  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,april #bh1 #bjbb,ms4 
,hirono submitt$ ! foll[+ resolution2   
:i* 0 ref]r$ to ! ,committee on ,heal?1 
,education1 ,labor1 & ,p5sions          
,,resolution  ,express+ support = !     
designation ( ,april #cj1 #bjbb1 z      
,national ,adult ,hepatitis ,b          
,vacc9ation ,aw>5ess ,day4  ,:]eas up to
 #b1djj1jjj individuals 9 ! ,unit$      
,/ates are *ronically infect$ )         
hepatitis ,b1 & up to two-?irds (       
individuals ) *ronic hepatitis ,b are   
unaw>e ( _! infection /atus2 ,:]eas     
hepatitis ,b is a viral infection ( !   
liv] transmitt$ via infect$ blood & o!r 
body fluids1 includ+ ?r\gh "m-to-*ild   
transmission & injection drug use2      
,:]eas hepatitis ,b is associat$ )      
significant disp>ities among-- 7#a7     
communities ( color1 includ+ ,asian     
,am]icans1 ,pacific ,isl&]s1 & ,african 
immigrants2  7#b7 sexual & g5d] m9ority 
communities2 &  7#c7 individuals affect$

 by ! opioid crisis2 ,:]eas individuals 
) *ronic diseases1 su* z diabetes1      
,,hiv1 hepatitis ,c1 & *ronic liv]      
disease1 & individuals on hemodialysis  
are at an increas$ risk = hepatitis ,b  
co-infection2 ,:]eas !re is no cure =   
hepatitis ,b1 & individuals ) *ronic    
hepatitis ,b require lifelong m$ical    
c>e2 ,:]eas *ronic hepatitis ,b         
repres5ts "o ( ! mo/ common causes (    
liv] canc]2 ,:]eas #a 9 e #d individuals
 ) unmanag$ *ronic hepatitis ,b w       
develop liv] canc]1 cirrhosis1 or liv]  
failure1 ) liv] canc] hav+ a #e-ye>     
survival rate ( only #ah p]c5t 9 !      
,unit$ ,/ates2 ,:]eas safe & highly     
effective vacc9es to protect aga9/      
hepatitis ,b are available2 ,:]eas1 9   
accordance ) univ]sal *ildhood hepatitis
 ,b vacc9ation recomm5dations 9 ! ,unit$
 ,/ates1 infants & *ildr5 h be5 r\t9ely 
vacc9at$ aga9/ hepatitis ,b s9ce !      
#aiijs2 ,:]eas all adults betwe5 ! ages 
( #ai & #ei & adults #fj & old] )       
hepatitis ,b risk factors are recomm5d$ 

to be vacc9at$ aga9/ hepatitis ,b2      
,:]eas ! hepatitis ,b vacc9e1 :i* is #ie
 p]c5t effective & 0 ! fir/ anticanc]   
vacc9e to be develop$1 is project$ to h 
prev5t$ #caj1jjj1jjj cases ( hepatitis  
,b worldwide betwe5 #aiij & #bjbj2      
,:]eas only #cj p]c5t ( adults 9 !      
,unit$ ,/ates are vacc9at$ aga9/        
hepatitis ,b2 ,:]eas ! numb] ( report$  
acute hepatitis ,b cases increas$ by #aa
 p]c5t 9 ! ,unit$ ,/ates betwe5 #bjad & 
#bjah2 ,:]eas1 z a result ( ! opioid    
epidemic1 !re h be5 significant regional
 increases 9 acute hepatitis ,b cases 9 
! ,unit$ ,/ates1 includ+-- 7#a7 a #dhi  
p]c5t increase betwe5 #bjae & #bjaf 9   
,ma9e2  7#b7 a report$ #aad p]c5t       
increase betwe5 #bjji & #bjac 9         
,k5tucky1 ,we/ ,virg9ia1 & ,t5nessee2   
7#c7 a report$ #gh p]c5t increase 9     
#bjag 9 s\!a/]n ,massa*usetts2 &  7#d7 a
 report$ #ef p]c5t increase betwe5 #bjad
 & #bjaf 9 ,nor? ,c>ol9a2 ,:]eas #cf    
p]c5t ( new hepatitis ,b cases are among
 individuals :o inject drugs2 ,:]eas1   

accord+ to ! ,c5t]s = ,disease ,control 
& ,prev5tion1 hepatitis ,b is #ej to    
#ajj times m infecti\s ?an ,,hiv & #e to
 #aj times m infecti\s ?an hepatitis ,c2
 & ,:]eas !re are significant           
opportunities1 p>ticul>ly )9 ! sett+ ( !
 opioid epidemic1 to prev5t new         
hepatitis ,b infections & !reby r$uce ! 
incid5ce ( liv] canc] & cirrhosis ?r\gh 
ef=ts to-- 7#a7 increase adult hepatitis
 ,b vacc9ation2 &  7#b7 ma9ta9 *ildhood 
hepatitis ,b vacc9ation3 ,n[1 !re=e1 be 
x  ,t ! ,s5ate-- 7#a7 supports !        
designation ( ,april #cj1 #bjbb1 z      
,national ,adult ,hepatitis ,b          
,vacc9ation ,aw>5ess ,day2  7#b7        
recognizes ! importance ( provid+       
support & enc\ragem5t-- 7,a7 = all      
individuals to be te/$ = hepatitis ,b2  
7,b7 = individuals susceptible to       
infection to be vacc9at$ aga9/ hepatitis
 ,b2 &  7,c7 = individuals diagnos$ )   
hepatitis ,b to be l9k$ to appropriate  
c>e2 &  7#c7 9 ord] to r$uce ! numb] (  
new hepatitis ,b infections & hepatitis 

,b-relat$ dea?s1 enc\rages a commitm5t  
to-- 7,a7 increas+ adult hepatitis ,b   
vacc9ation rates2  7,b7 ma9ta9+ *ildhood
 hepatitis ,b vacc9ation rates2 &  7,c7 
promot+ provid] & community aw>5ess (   
adult hepatitis ,b vacc9ation4